Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.

    Transthyretin Amyloidosis: CRISPR-Cas9 Technology Shows Results in a Single Treatment

    In August of 2021, Intellia Therapeutics of Cambridge and its partner Regeneron Pharmaceuticals published a study reported in the Boston Globe, showing results of a single treatment using CRISPR-Cas9 technology.…

    Continue Reading Transthyretin Amyloidosis: CRISPR-Cas9 Technology Shows Results in a Single Treatment

    A UConn Health Team Administers the World’s First Gene Therapy for Glycogen Storage Disease Type-1a

    In January of this year, a University of Connecticut (UConn) team administered the world’s first infusion of a new gene therapy as part of a long-awaited clinical trial. According to…

    Continue Reading A UConn Health Team Administers the World’s First Gene Therapy for Glycogen Storage Disease Type-1a

    Have You Ever Been Denied a Diagnosis And Told That Your Pain is Psychosomatic? Part Two

    Note: This is part two of a two part story. Don't forget to go back and read part one! Meghan O’Rouke, the author of the NYT best-selling book Invisible Kingdom,…

    Continue Reading Have You Ever Been Denied a Diagnosis And Told That Your Pain is Psychosomatic? Part Two

    The Nanopore Sequencing Test Reduces Diagnosis From Decades to Days for Multiple Rare Disorders

    Researchers from Australia’s Garvan Institute have joined with collaborators in Israel and the UK in identifying neuromuscular and neurological genetic diseases that have been difficult to diagnose due to the…

    Continue Reading The Nanopore Sequencing Test Reduces Diagnosis From Decades to Days for Multiple Rare Disorders
    Two ALS Studies May Unravel its Genetic Roots and Solve One of its Mysteries
    source: shutterstock.com

    Two ALS Studies May Unravel its Genetic Roots and Solve One of its Mysteries

    Scientists at London’s University College and a team of scientists at Stanford University simultaneously made the same discovery about amyotrophic lateral sclerosis (ALS): the genetic variant in the protein UNC13A…

    Continue Reading Two ALS Studies May Unravel its Genetic Roots and Solve One of its Mysteries

    Studies Show Favorable Results For PARP Inhibitors in the Treatment of Advanced Ovarian Cancer

    Dr. Rachel Grisham MSK ovarian cancer section head discussed clinical trials investigating PARP inhibitors for ovarian cancer patients. The event was a round table discussion and interview for Targeted Oncology.…

    Continue Reading Studies Show Favorable Results For PARP Inhibitors in the Treatment of Advanced Ovarian Cancer